How Can We Help You?
There may be options to help you afford RITUXAN, no matter what type
of health insurance you have.
Referrals to Independent Co-pay Assistance Foundations
If you need help with the co-pay for RITUXAN, RITUXAN Access Solutions can refer you to an independent co-pay assistance foundation.
An independent co-pay assistance foundation is a charitable
organization that gives financial assistance for medicines.
Call RITUXAN Access Solutions at (888) 249-4918 for a referral.
If you would like to contact a foundation directly, you can use the information below:
Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma
Independent co-pay assistance foundations have their own rules for
eligibility. We cannot guarantee a foundation will help you. We only
can refer you to a foundation that supports your disease state. This
information is provided as a resource for you. We do not endorse or
show financial preference for any particular foundation. The
foundations in this list are not the only ones that might be able to
help you.
Referrals to the Genentech Patient Foundation
The Genentech® Access to Care Foundation is now the Genentech Patient Foundation.
We are still focused on giving free medicines to patients in need, but we've made some changes to provide better support to more patients, more quickly.
The Genentech Patient Foundation provides free medicines to
people:
- Who don't have insurance
- Whose treatment is not covered by insurance
- Who
are struggling with high out-of-pocket costs
To learn more and to apply for help, visit GenentechPatientFoundation.com.
You have to fill out Sections 5 and 6 of the PAN form to apply for
GATCF.
If you have health insurance coverage for your medicine, you must
have already tried other types of patient assistance to qualify for
free RITUXAN from the Genentech Patient Foundation. This includes
the Genentech BioOncology Co-pay Card and support from independent
co-pay assistance foundations. You must also meet financial
criteria. If you do not have insurance, you must meet different
financial criteria.
Referrals to the Genentech BioOncology Co-pay Card
RITUXAN Access Solutions can refer you to the Genentech BioOncology Co-pay Card. It can help you with the out-of-pocket costs for RITUXAN, if you’re eligible.
The Genentech BioOncology Co-pay Card helps patients with commercial
health insurance. This might be a plan you get through your employer
or one you purchased through a Health Insurance Marketplace like
HealthCare.gov. To qualify, you must also meet other criteria.
In order to be eligible for the Genentech BioOncology Co-pay Card,
the patient must have commercial insurance, must not have Medicare,
Medicaid or other government insurance, and must meet other
eligibility criteria. They also must agree to the rules set forth in
the terms and conditions for the program. Please visit CopayAssistanceNow.com for the full list of
terms and conditions.
How to Work With RITUXAN Access Solutions
Step 2
We work with you, your doctor’s office, your health insurance plan and your specialty pharmacy. We might contact you for more information.
PAN=Patient Authorization and Notice of Request
for Transmission of Health Information to Genentech Access Solutions
and Genentech® Access to Care Foundation.
SMN=Statement
of Medical Necessity.
Important Safety Information & Indication
What it Treats
RITUXAN® (Rituximab) is indicated for the treatment of:
- Low-grade or follicular CD20-positive non-Hodgkin’s lymphoma as a single-agent therapy in patients whose disease recurred or did not respond to initial treatment
- Follicular CD20-positive non-Hodgkin’s lymphoma as an initial treatment with chemotherapy, and in patients whose initial treatment was successful, as a single- agent follow-up therapy
- Low-grade CD20-positive non-Hodgkin’s lymphoma as a single-agent follow-up therapy for patients who did not progress on initial treatment with CVP chemotherapy
- CD20-positive diffuse large B-cell non-Hodgkin’s lymphoma as an initial treatment in combination with CHOP chemotherapy
- CD20-positive chronic lymphocytic leukemia in combination with FC chemotherapy as an initial treatment or as a treatment after disease has recurred
People with serious infections should not receive RITUXAN.
It is not known if RITUXAN is safe or effective in children.
Important Safety Information
What is the most important information I should know about RITUXAN?
Tell your doctor right away about any side effect you experience. RITUXAN can cause serious side effects that can lead to death, including:
- Infusion Reactions: may occur during or within 24 hours of your infusion. Your doctor should give you medicines before your treatment. Symptoms can include hives, rash, itching, facial or oral swelling, sudden cough, shortness of breath, difficulty breathing, weakness, dizziness, feeling faint, racing heart, or chest pain
- Severe Skin and Mouth Reactions: symptoms can include painful sores, ulcers, or blisters on your skin, lips or mouth; peeling skin; rash; or pustules
- Hepatitis B Virus (HBV) Reactivation: may cause serious liver problems including liver failure and death. If you have had hepatitis B or are a carrier of HBV, receiving RITUXAN could cause the virus to become an active infection again. You should not receive RITUXAN if you have active HBV liver disease. Your doctor will do blood tests to check for HBV infection prior to treatment and will monitor you during and for several months following your treatment
- Progressive Multifocal Leukoencephalopathy (PML): a rare, serious brain infection that can lead to severe disability and death and for which there is no known prevention, treatment, or cure. Symptoms can include difficulty thinking, loss of balance, changes in speech or walking, weakness on one side of your body, or blurred or lost vision
What are the additional possible serious side effects of RITUXAN?
Tell your doctor right away about any side effect you experience. RITUXAN can cause serious side effects that can lead to death, including:
- Tumor Lysis Syndrome (TLS): may cause kidney failure and the need for dialysis treatment, abnormal heart rhythm, and can lead to death. Your doctor may give you medicines before your treatment to help prevent TLS
- Serious Infections: can happen during and after treatment and can lead to death.
These infections may be bacterial, fungal, or viral. Symptoms can include fever; cold or flu symptoms; earache or headache; pain during urination; white patches in the mouth or throat; cuts or scrapes that are red, warm, swollen, or painful - Heart Problems: symptoms can include chest pain and irregular heartbeats that may require treatment. Your doctor may need to stop your treatment
- Kidney Problems: your doctor should do blood tests to check how well your kidneys are working
- Stomach and Serious Bowel Problems: can include blockage or tears in the bowel that can lead to death. Stomach area pain during treatment can be a symptom
- Low Blood Cell Counts: your blood cell counts may be monitored during treatment
The most common side effects of RITUXAN are infusion reactions, chills, infections, body aches, tiredness, and low white blood cells.
Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. It is not known if RITUXAN may harm your unborn baby or pass into your breast milk. Women should use birth control while using RITUXAN and for 12 months after treatment.
Tell your doctor about any side effect that bothers you or that does not go away. These are not all of the possible side effects of RITUXAN. For more information, ask your doctor or pharmacist.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835- 2555.
Please see the RITUXAN full Prescribing Information, including the Medication Guide, for additional Important Safety Information.